At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NDRA ENDRA Life Sciences Inc
Post-Mkt 10-14 17:38:49 EDT
4.78
-0.26
-5.26%
High5.10
Low4.73
Vol15.03K
Open5.00
D1 Closing5.04
Amplitude7.32%
Mkt Cap7.16M
Tradable Cap6.50M
Total Shares1.50M
T/O73.52K
T/O Rate1.10%
Tradable Shares1.36M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
ENDRA Life Sciences Initial Beneficial Ownership Statement Lists ASP Isotopes as 10% Owner
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.